Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkersSophia Weiner, Johan Gobom, Egor Vorontsov et al.|Clinical Proteomics|2022Cited by 30
Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalusSophia Weiner, Johan Gobom, Kaj Blennow et al.|Fluids and Barriers of the CNS|2023Cited by 18
SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's diseaseSophia Weiner, Johan Gobom, Bengt Nellgård et al.|Alzheimer s & Dementia|2023Cited by 9
Cerebrospinal fluid proteome profiling across the Alzheimer’s disease continuum: a step towards solving the equation for ‘X’Sophia Weiner, Johan Gobom, Joseph Therriault et al.|Molecular Neurodegeneration|2025Cited by 4
Clinical proteomic analysis across the Alzheimer’s disease continuumSophia Weiner, Johan Gobom, Nicholas J. Ashton et al.|Alzheimer s & Dementia|2023Cited by 1